{
  "results": [
    {
      "title": "Innovent Biologics Showcases \"Dual Innovations\" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms",
      "description": "SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major...",
      "image_url": "https://bloximages.chicago2.vip.townnews.com/elkodaily.com/content/tncms/assets/v3/editorial/2/97/297dc2b4-bf19-5125-a928-2787228e399e/68625acbaffcf.image.jpg?resize=300%2C186",
      "link": "https://elkodaily.com/online_features/press_releases/article_e68a9035-36b7-5466-9e5a-a8d0da62906a.html"
    },
    {
      "title": "Innovent Biologics Showcases \"Dual Innovations\" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms",
      "description": "SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major...",
      "image_url": "https://bloximages.chicago2.vip.townnews.com/dailyrepublic.com/content/tncms/assets/v3/editorial/4/7e/47e1e6c7-552e-5fb2-b859-638101d393f2/68625b6f01356.image.jpg?resize=300%2C186",
      "link": "https://www.dailyrepublic.com/online_features/press_releases/innovent-biologics-showcases-dual-innovations-at-oncology-r-d-day-pioneering-the-future-of-cancer/article_60080f2c-e971-5f43-85ff-487e81991f66.html"
    },
    {
      "title": "Innovent Biologics Showcases \"Dual Innovations\" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms",
      "description": "SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major...",
      "image_url": "https://bloximages.chicago2.vip.townnews.com/tdn.com/content/tncms/assets/v3/editorial/6/a3/6a355258-b89d-5567-9002-15b24bcaeb66/68625b50355bc.image.jpg?crop=1286%2C675%2C0%2C60&order=crop%2Cresize&resize=1200%2C630",
      "link": "https://tdn.com/online_features/press_releases/article_7082d109-0c57-5d1d-a544-ff6a3d36adb9.html"
    }
  ]
}